RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 34-44
  • Bad news on red meat: Eating more is linked to diabetes risk

    Bad news on red meat: Eating more is linked to diabetes risk
    Nutritionists known for issuing warnings about the health risks of eating red meat reiterated their message this week, confirming a link between red meat consumption and Type 2 diabetes -- and showing, in a new follow-up study, that the association...
  • Blood tests could detect sexually-transmitted oral cancers

    Blood tests could detect sexually-transmitted oral cancers
    LONDON (Reuters) - Antibodies to a high-risk type of a virus that causes mouth and throat cancers when transmitted via oral sex can be detected in blood tests many years before onset of the disease, according to a World Health Organisation-led team of...
  • Insight: No smoke, plenty of fire fuels e-cigarettes

    Insight: No smoke, plenty of fire fuels e-cigarettes
    Puffing on slim metal tubes loaded with pale yellow liquid, two London businessmen say they have between their lips a cure for what the U.N. calls "one of the biggest public health threats the world has ever faced". Electronic cigarettes are the future,...
  • FDA panel recommends continued Avandia sales, with restrictions

    FDA panel recommends continued Avandia sales, with restrictions
    An advisory panel to the Food and Drug Administration on Thursday voted to keep the diabetes drug Avandia on the market with a slate of restrictions on its use, and suggested that although evidence of the drug's safety problems may have been overblown,...
  • Avandia review by FDA examines whether dangers were overdrawn

    Avandia review by FDA examines whether dangers were overdrawn
    Three years after the Food and Drug Administration was taken to task for overlooking safety problems with the diabetes drug Avandia, a panel of FDA advisors met Wednesday to open a two-day review of the research that guided the agency's actions. The...
  • Infertility due to old eggs? An anti-aging pioneer ponders solutions

    Infertility due to old eggs? An anti-aging pioneer ponders solutions
    One of the many ways in which humans' evolved characteristics clash with a fast-changing post-industrial society can be seen in the female egg. Even before a woman passes the age of 30, the quality of the oocytes she carries begins a downturn in...
  • Quit-smoking treatments safe, effective: review

    Quit-smoking treatments safe, effective: review
    NEW YORK (Reuters Health) - Popular smoking cessation treatments - such as nicotine replacements and antidepressants - improve people's chances of kicking the habit without much risk, according to a review of past research. "It seems very clear that...
  • Glaxo anti-cancer cocktail gets regulatory approval

    Glaxo anti-cancer cocktail gets regulatory approval
    After her melanoma, Cheryl Stratos is mostly back to a normal life, running a business and driving her teenage son to weekend events, but there are reminders that it could all come back: The sores all over her body, the high fevers, the hair loss --...
  • FDA approves skin cancer drugs and genetic test

    FDA approves skin cancer drugs and genetic test
    The Food and Drug Administration on Wednesday announced its approval of two new drugs and a diagnostic test that can be used to treat advanced or inoperable melanoma, the most dangerous form of skin disease. Advanced melanoma has joined a wide range...
  • Athletes only too happy to be 'lab rats'

    Athletes only too happy to be 'lab rats'
    After discovering that a promising new drug caused multiple types of cancer in lab animals, the pharmaceutical company GlaxoSmithKline stopped developing the compound. But the failed experimental drug, called GW501516, is making a comeback in another...
  • Big pharma: Few new antibiotics in the works

    Big pharma: Few new antibiotics in the works
    Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines. Today, as the world confronts the crisis of antibiotic resistance, the industry...